Recurrent infusion phlebitis induced by cyclosporine

Annals of Pharmacotherapy

Volumn 38, Issue 12, 2004, Pages 2071-2073

  Rottenberg, Yakir ^a   Fridlender, Zvi G ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Cyclosporine; Infusion phlebitis

Indexed keywords

CYCLOSPORIN; HYDROCORTISONE; METHOTREXATE;

ADULT; ANAMNESIS; ARTICLE; BRONCHOSPASM; CASE REPORT; CLINICAL FEATURE; DISEASE EXACERBATION; EDEMA; ERYTHEMA; HUMAN; HYPERSENSITIVITY; INTRAVENOUS CATHETER; MALE; PHLEBITIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REMISSION; SKIN INDURATION; TREATMENT OUTCOME; ULCERATIVE COLITIS; VEIN CATHETERIZATION; WHEEZING;

ADULT; ANTI-INFLAMMATORY AGENTS; COLITIS, ULCERATIVE; CYCLOSPORINE; HUMANS; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENTS; INFUSIONS, INTRAVENOUS; MALE; PHLEBITIS; RECURRENCE;

EID: 12844253687     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1E209     Document Type: Article

References (16)

1. Monreal M, Quilez F, Rey-Joly C, Rodriguez S, Sopena N, Neira C, et al. Infusion phlebitis in patients with acute pneumonia - a prospective study. Chest 1999;115:1576-80. DOI 10.1378/chest.115.6.1576
2. Tagalakis V, Kahn SR, Libman M, Blostein M. The epidemiology of peripheral vein infusion thrombophlebitis: a critical review. Am J Med 2002;113:146-51. DOI 10.1016/S0002-9343(02)01163-4
3. Falchuk KH, Peterson L, McNeil BJ. Microparticulate-induced phlebitis. Its prevention by in-line filtration. N Engl J Med 1985;312:78-82.
4. Macklin D. Phlebitis. Am J Nurs 2003;103:55-60.
5. Parekh K, Trulock E, Patterson GA. Use of cyclosporine in lung transplantation. Transplant Proc 2004;36:318S-22S. DOI 10.1016/j.transproceed. 2004.01.056
6. Conti F, Priori R, Alessandri C, Spinelli FR, Medda E, Valesini G. Safety profile and causes of withdrawal due to adverse events in systemic lupus erythematosus patients treated long-term with cyclosporine A. Lupus 2000;9:676-80. DOI 10.1191/096120300676096627
7. Podolsky D. Inflammatory bowel disease. N Engl J Med 2002;347:417-29. DOI 10.1056/NFJMra020831
8. Package insert. Sandimmun (cyclosporine). Basel, Switzerland: Novartis Pharma, 2002.
9. Lanbeck P, Odenholt I, Paulsen O. Antibiotics differ in their tendency to cause infusion phlebitis: a prospective observational study. Scand J Infect Dis 2002;34:512-9. DOI 10.1080/00365540110080908
10. Dalibon N, Stern M, Bonnette P, Dreyfus G, Fischler M. Probable allergic reaction to cyclosporine and early formation of thrombi on a pulmonary artery catheter: two unusual complications during bilateral lung transplantation. Br J Anaesth 2002;89:930-3. DOI 10.1093/bja/aef272
11. Gelderblom H, Verweij J, Nooter K, Sparreboom A. Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur J Cancer 2001;37:1590-8. DOI 10/1016/s0959-8049(01)00171-X
12. Liau-Chu M, Theis JG, Koren G. Mechanism of anaphylactoid reactions: improper preparation of high-dose intravenous cyclosporine leads to bolus infusion of Cremophor EL and cyclosporine. Ann Pharmacother 1997; 31:1287-91.
13. Vassilomanolakis M, Koumakis G, Barbounis V, Orphanos G, Efremidis A. Prevention of vinorelbine phlebitis with cimetidine - a two-step design study. Support Care Cancer 2001;9:108-11. DOI 10.1007/s005200000190
14. Payne-James JJ, Bray MJ, Kapadia S, Rana SK, McSwiggan D, Silk DB. Topical nonsteroidal anti-inflammatory gel for the prevention of peripheral vein thrombophlebitis. A double-blind, randomised, placebo-controlled trial in normal subjects. Anaesthesia 1992;47:324-6.
15. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
16. Hafner JW, Bellknap SM, Squillante MD, Bucheit KA. Adverse drug events in emergency department patients. Ann Emerg Med 2002;39:258-67. DOI 10.1067/mem.2002.121401